The effects of ondansetron on diabetes and high-fat diet-induced liver disease: a critical role for protein tyrosine phosphatase 1B

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Frontiers in Pharmacology vol. 16 (Apr 2025), p. 1565628-1565644
1. Verfasser:	Naeem, Fawad
Weitere Verfasser:	Aqeel, Maryam, Muhammad Ammar Zahid, Mustafeez Mujtaba Babar, Fawad Ali Shah, Agouni, Abdelali, Sohaib Zafar Malik
Veröffentlicht:	Frontiers Media SA
Schlagworte:	Food & Drug Administration > FDA United Kingdom > UK New York United States > US Diabetes Insulin resistance Hydrogen bonds High fat diet Binding sites Fatty liver Drug development Blood levels Computer applications Metabolism Inflammation Liver diseases Apoptosis Metabolic disorders Proteins Protein-tyrosine-phosphatase Therapeutic applications Simulation Phosphatase Insulin FDA approval Oxidative stress Glucose Diabetes mellitus Tumor necrosis factor-TNF Ligands Homeostasis Allosteric properties Enzymes
Online-Zugang:	Citation/Abstract Full Text Full Text - PDF
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!

Schreiben Sie den ersten Kommentar!